Search Results - "Bhardwaj, Rukmini"

Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway by Bhardwaj, Rukmini, Suzuki, Akiko, Leland, Pamela, Joshi, Bharat H, Puri, Raj K

“…Previously, we have demonstrated that Interleukin 13 receptor alpha 2 (IL-13Rα2) is overexpressed in approximate 78% Glioblastoma multiforme (GBM) samples. We…”
Get full text

Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis by Wang, Lili, Bhardwaj, Rukmini, Mostowski, Howard, Patrone, Paul N, Kearsley, Anthony J, Watson, Jessica, Lim, Liang, Pichaandi, Jothir, Ornatsky, Olga, Majonis, Daniel, Bauer, Steven R, Degheidy, Heba A

“…In the field of cell-based therapeutics, there is a great need for high-quality, robust, and validated measurements for cell characterization. Flow cytometry…”
Get full text

Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial by Singh, Kavita, Mukherjee, Paushali, Shakri, Ahmad Rushdi, Singh, Ankita, Pandey, Gaurav, Bakshi, Meenakshi, Uppal, Geetanjali, Jena, Rajender, Rawat, Ankita, Kumar, Purnima, Bhardwaj, Rukmini, Yazdani, Syed Shams, Hans, Dhiraj, Mehta, Shantanu, Srinivasan, Ajay, Anil, K., Madhusudhan, R. L., Patel, Jaya, Singh, Amit, Rao, Rajeshwar, Gangireddy, Santosh, Patil, Rudrappa, Kaviraj, Swarnendu, Singh, Sanjay, Carter, Darrick, Reed, Steve, Kaslow, David C., Birkett, Ashley, Chauhan, Virander S., Chitnis, Chetan E.

“…Reticulocyte invasion by Plasmodium vivax requires interaction of the Duffy-binding protein (PvDBP) with host Duffy antigen receptor for chemokines (DARCs)…”
Get full text

Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria by He, Wen-Qiang, Shakri, Ahmad Rushdi, Bhardwaj, Rukmini, França, Camila T, Stanisic, Danielle I, Healer, Julie, Kiniboro, Benson, Robinson, Leanne J, Guillotte-Blisnick, Micheline, Huon, Christèle, Siba, Peter, Cowman, Alan, King, Christopher L, Tham, Wai-Hong, Chitnis, Chetan E, Mueller, Ivo

“…The Plasmodium vivax Duffy Binding Protein (PvDBP) is a key target of naturally acquired immunity. However, region II of PvDBP, which contains the…”
Get full text

Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175 by Chitnis, Chetan E, Mukherjee, Paushali, Mehta, Shantanu, Yazdani, Syed Shams, Dhawan, Shikha, Shakri, Ahmad Rushdi, Bhardwaj, Rukmini, Bharadwaj, Rukmini, Gupta, Puneet Kumar, Hans, Dhiraj, Mazumdar, Suman, Singh, Bijender, Kumar, Sanjeev, Pandey, Gaurav, Parulekar, Varsha, Imbault, Nathalie, Shivyogi, Preethi, Godbole, Girish, Mohan, Krishna, Leroy, Odile, Singh, Kavita, Chauhan, Virander S

“…A phase I randomised, controlled, single blind, dose escalation trial was conducted to evaluate safety and immunogenicity of JAIVAC-1, a recombinant blood…”
Get full text

Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine development by Bhardwaj, Rukmini, Shakri, Ahmad Rushdi, Hans, Dhiraj, Gupta, Pankaj, Fernandez-Becerra, Carmen, del Portillo, Hernando A., Pandey, Gaurav, Chitnis, Chetan E.

“…Plasmodium vivax is dependent on interaction with the Duffy antigen receptor for chemokines (DARC) for invasion of human erythrocytes. The P. vivax Duffy…”
Get full text

Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175 by Chitnis, Chetan E, Mukherjee, Paushali, Mehta, Shantanu, Yazdani, Syed Shams, Dhawan, Shikha, Shakri, Ahmad Rushdi, Bhardwaj, Rukmini, Gupta, Puneet Kumar, Hans, Dhiraj, Mazumdar, Suman, Singh, Bijender, Kumar, Sanjeev, Pandey, Gaurav, Parulekar, Varsha, Imbault, Nathalie, Shivyogi, Preethi, Godbole, Girish, Mohan, Krishna, Leroy, Odile, Singh, Kavita, Chauhan, Virander S

“…[This corrects the article DOI: 10.1371/journal.pone.0117820.]…”
Get full text

ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans by Chung, Ka Yan, Coyle, Elizabeth M, Jani, Dewal, King, Lisa R, Bhardwaj, Rukmini, Fries, Louis, Smith, Gale, Glenn, Gregory, Golding, Hana, Khurana, Surender

“…Highlights • H7N9 VLP vaccine with ISCOMATRIX™ adjuvant showed enhanced neutralizing antibody responses in humans. • Unadjuvanted H7N9-VLP vaccine generated…”
Get full text

Abstract 4900: Cysteamine suppresses tumor metastasis by inhibiting activity of matrix metalloproteases without inducing toxicity in mouse models of human ovarian cancer by Suzuki, Akiko, Bhardwaj, Rukmini, Leland, Pamela, Joshi, Bharat H., Puri, Raj K.

“…Previously, we demonstrated that cysteamine, a small molecule inhibitor of matrixmetalloproteases (MMPs), inhibited tumor invasion in vitro and metastasis in…”
Get full text

Abstract 2438: Analysis of IL-13 signaling through IL-13Rα2 in human brain tumor specimens in situ by Bhardwaj, Rukmini, Suzuki, Akiko, Leland, Pamela, Joshi, Bharat H., Puri, Raj K.

“…Previously, we have demonstrated that IL-13 receptor alpha2 (IL-13Rα2), a high affinity receptor for Th2 cytokine IL-13, is overexpressed in most glioblastoma…”
Get full text

Identification of a novel role of IL-13R[alpha]2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway by Bhardwaj, Rukmini, Suzuki, Akiko, Leland, Pamela, Joshi, Bharat H, Puri, Raj K

“…Background Previously, we have demonstrated that Interleukin 13 receptor alpha 2 (IL-13R[alpha]2) is overexpressed in approximate 78% Glioblastoma multiforme…”
Get full text

Targeting TLRs expands the antibody repertoire in response to a malaria vaccine by Wiley, Steven R, Raman, Vanitha S, Desbien, Anthony, Bailor, Hilton R, Bhardwaj, Rukmini, Shakri, Ahmed Rushdi, Reed, Steven G, Chitnis, Chetan E, Carter, Darrick

“…Vaccination with an isolated antigen is frequently not sufficient to elicit a protective immune response. The addition of adjuvants to the antigen can increase…”
Get more information

Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175: e0137816 by Chitnis, Chetan E, Mukherjee, Paushali, Mehta, Shantanu, Yazdani, Syed Shams, Dhawan, Shikha, Shakri, Ahmad Rushdi, Bhardwaj, Rukmini, Gupta, Puneet Kumar, Hans, Dhiraj, Mazumdar, Suman

Get full text